004720 — PharmGen Science Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Market Cap
KR₩80bn
Enterprise Value
KR₩64bn
Revenue
KR₩173bn

Annual balance sheet for PharmGen Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	34,187	19,886	37,437	37,916	21,881
Net Total Accounts Receivable
Net Total Receivables	20,166	28,638	36,414	39,662	44,352
Total Inventory
Total Other Current Assets
Total Current Assets	77,379	70,541	95,327	110,709	96,065
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34,902	42,444	41,273	38,863	38,201
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	220,324	317,391	335,917	363,450	195,414
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	71,122	68,185	63,172	65,422	33,679
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	93,384	110,267	107,696	114,011	49,110
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	126,940	207,125	228,221	249,439	146,304
Total Liabilities & Shareholders' Equity	220,324	317,391	335,917	363,450	195,414
Total Common Shares Outstanding